Sinohealth Holdings Ltd. (HK:2361) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sinohealth Holdings Ltd. has reported a significant growth in its interim results for the first half of 2024, with a 10.1% increase in revenue and a notable 62.1% rise in operating profit. The company’s net profit, excluding exchange gains and losses, climbed by 23.2%, reflecting a robust improvement in operating efficiency and product innovation. The health industry-focused tech firm also saw an increase in corporate customers and a high repurchase rate among leading pharmaceutical clients.
For further insights into HK:2361 stock, check out TipRanks’ Stock Analysis page.